Type 1 diabetes mellitus and Down's syndrome: Prevalence, management and diabetic complications

Diabetic Medicine

Volumn 15, Issue 2, 1998, Pages 160-163

  Anwar, A J ^a   Walker, J D ^a,b   Frier, B M ^a  

^a NHS LOTHIAN   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Diabetic complications; Down's syndrome; Insulin; Insulin dependent diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIFESTYLE; MALE; PREVALENCE; UNITED KINGDOM;

ADULT; AGE OF ONSET; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DOWN SYNDROME; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; PREVALENCE; SCOTLAND; TRIGLYCERIDES;

EID: 0031882343     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J     Document Type: Article

References (19)

1. Down JL. Observations on an ethnic classification of idiots. London Hospital Reviews 1866; 3: 259-262.
2. Milunsky A, Neurath PW. Diabetes mellitus in Down's syndrome. Archives of Environmental Health 1968; 17: 373-376.
3. Farquhar JW. Diabetic children in Scotland and the need for care. Scot Med journal 1962; 7: 119-124.
4. Schoffling K, Schade C. Diabetes mellitus and impaired glucose tolerance in diseases with chromosomal aberrations. In: Creutzfeld W, Kobberling J, Neel JV, eds. The Genetics of Diabetes Mellitus. Berlin: Springer Verlag, 1976: 125-137.
5. Murdoch J. A survey of Down's syndrome under general practitioner care in Scotland. J Roy Coll Gen Pract 1982; 32: 410-418.
6. Steele J, Stratford B. The United Kingdom population with Down's syndrome: present and future projections. American Journal of Mental Retardation 1995; 99: 664-683.
7. Fleiss JL. Statistical Methods for Rates and Proportions, 2nd edn. New York: Wiley, 1981: 14-17.
8. Gray A, Fenn P, McGuire A. The cost of insulin-dependent diabetes mellitus (IDDM) in England and Wales. Diabetic Med 1995; 12: 1068-1076.
9. Neil AW, Gatling W, Mather HM, Thompson AV, Thorogood M, Fowler GH, et al. The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabetic Med 1987; 4: 539-543.
10. Bingley PJ, Gale EAM. Incidence of insulin dependent diabetes in England: a study in the Oxford region. Br Med J 1989; 289: 558-560.
11. Kennedy RL, Jones TH, Cuckle HS. Down's syndrome and the thyroid. Clin Endocrinol 1992; 37: 471-476.
12. Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfuction in diabetic patients: value of annual review. Diabetic Med 1995; 12: 622-627.
13. Griffin ME, Fulcher T, Nikookam K, Crowley J, Firth RG, O'Meara NM. Down's syndrome, IDDM, and hypothyroidism. Diabetes Care 1997; 20: 1202-1203.
14. Rich SS. Mapping genes in diabetes. Diabetes 1990; 39: 1315-1319.
15. Gorsuch A. The immunogenetics of diabetes. Diabetic Med 1987; 4: 510-516.
16. Keen H. The genetics of diabetes: from nightmare to headache. Br Med J 1987; 294: 917-918.
17. Todd JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JRS, Hearne CM, et al. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature 1991; 351: 542-547.
18. Nishida Y, Akaoka I, Nishizawa T, Maruki M, Maruki K. Hyperlipidaemia in patients with Down's syndrome. Atherosclerosis 1977; 26: 373-377.
19. Pueshell FM, Craig WY, Haddow JE. Lipids and lipoproteins in persons with Down's syndrome. J Intell Disabil Res 1992; 36: 365-369.